20 June 2020

• Favipiravir, an oral antiviral, is approved for treatment of mild-to-moderate COVID-19 in India, marketed as FabiFlu. Source
• Brazil reaches 1 million cases of COVID-19, and almost 49,000 people have died from it. Source
• Brazil launches Latin America’s first phase III vaccine trial of Oxford’s ChAdOx1 nCoV-19 candidate; it will focus on front-line healthcare workers. The trial is being sponsored by the non-profit Lemann Foundation. Sources 1,2,3

Return to the timeline